Equity Research Report: Constellation Energy Corporation ($CEG)
Current Price: $286.31 | Rating: BUY | Fair Value: $345 | 12-Mo Target: $335
One-Page Summary
Constellation Energy is the irreplaceable backbone of US nuclear baseload power at a moment when AI-driven data center demand is converting electrons into the new strategic resource — and the stock is down 29% from its October 2025 all-time high of $403.95 as the market digests $11.1B of Calpine merger goodwill, 13.8% share dilution, doubled short interest, and a death-cross technical posture. We rate CEG a BUY with $345 fair value and a 12-month target of $335 (+17%), staged in on weakness in the $260–$290 corridor: the structural thesis — 60 GW post-merger fleet, 20-year hyperscaler PPAs with Microsoft and Meta, $5B buyback authorization, reaffirmed $11–$12 FY26 EPS guide — remains intact, but resolution must come from concrete catalysts (PJM 2028/29 BRA in June 2026, FERC Eddystone ruling Q3 2026, NRC Crane final approval Q4 2026) before the multiple re-rates.
Top 5 Reasons:
- Wide, regulatorily-unrepeatable moat. 21 reactors, ~22 GW pre-merger / ~60 GW post-Calpine. No new US merchant nuclear plant has entered commercial operation since the early 1990s; NRC license extensions through 2047–2051 are sunk costs no competitor can match.
- Locked-in hyperscaler revenue. Microsoft 20-year PPA for 835 MW (Three Mile Island/Crane), Meta 20-year PPA for 1.1 GW (Clinton, starting June 2027). Premium pricing far above merchant rates from investment-grade counterparties.
- Forward earnings power priced at 24.4x. $11.50 midpoint FY26 guide, 20%+ guided EPS CAGR, $5B buyback authorization at current depressed prices — accretive math regardless of merger noise.
- PJM capacity tailwind. 2027/28 BRA cleared at the $333.44/MW-day cap; CEG cleared ~17.95 GW = ~$2.2B capacity revenue for that delivery year. The 2028/29 auction in June 2026 likely sustains elevated pricing on continued supply shortfall.
- Insider ECP overhang already in the market. ECP ControlCo's 22M shares (filed 13G Jan 14, 2026) are the dilutive incumbent — not a future surprise. Death-cross + 10.5M short interest reflects this digesting, not a new threat.
1. Company Overview
Constellation Energy Corporation (NASDAQ-GS: CEG) is the largest US producer of carbon-free electricity by output and the operator of the country's largest nuclear fleet. Spun off from Exelon on February 1, 2022, CEG has operated 21 reactors at 12 plants generating 22 GW. The transformational January 7, 2026 close of the Calpine acquisition ($16.4B EV, 50M CEG shares + $4.5B cash) added ~23 GW of largely natural-gas and geothermal capacity plus a retail electricity platform, bringing pro-forma fleet to ~60 GW and making CEG the nation's largest competitive generator across both carbon-free baseload and dispatchable gas peaking.
The investment thesis is bifurcated. Long-term: CEG's existing nuclear fleet is the only economic mass-baseload source of 24/7 carbon-free power available to AI data center hyperscalers, who have signed >9.8 GW of nuclear PPAs globally since 2024. Near-term: a $103B market cap utility that doubled its debt, diluted its share count 13.8%, and traded with semiconductor-adjacent multiples must now grow into a leveraged utility-with-optionality framing — a process that is producing the current drawdown, doubled short interest, and rotation pressure.
2. Price Chart
5-year daily close (post-spinoff) with 50-day (orange dashed) and 200-day (red dashed) simple moving averages. Source: Nasdaq historical, May 28, 2026.
3. Technical Setup
CEG is in a primary downtrend with weakening momentum: price is below both the 50-day SMA ($293.10) and 200-day SMA ($323.48), with the 50MA < 200MA death-cross posture intact, though recent stabilization (+1.80% 1W) suggests potential support-bounce rather than capitulation.
Wyckoff Phase: Distribution transitioning into early Markdown. The ~29% drawdown from the October 15, 2025 ATH ($403.95) combined with doubling short interest (4.94M → 10.53M shares) indicates institutional unloading, now testing support structures with potential Phase C (final shakeout) near the S1 level ($247.06).
Key Levels:
| Level | Price | Significance |
|---|---|---|
| R2 (5yr ATH close) | $403.95 | Sellers' stronghold; Oct 15, 2025 peak |
| R1 (200d high close) | $403.95 | Resistance convergence |
| 200-day SMA | $323.48 | Primary trend filter; downtrend confirmation |
| 50-day SMA | $293.10 | Intermediate support; price 2.3% below |
| Current Price | $286.31 | Support test zone |
| S1 (200d low close) | $247.06 | Structural support; 1Y profit-taking level |
| S2 (post-IPO low) | $41.90 | Post-spinoff floor (Jan 25, 2022) |
Entry Strategy:
- Bullish: Buy zone $273–$283 (50MA support + recent stabilization), stop loss $242 (below S1)
- Bearish: Short zone $305–$315 (200MA reclaim resistance), stop loss $330 (above 200MA)
Tactical read: Price must reclaim the 50-day SMA ($293.10) on volume to invalidate the death cross. Target $380 (1Y analyst consensus) is valid only after a confirmed breakout above $305 resistance.
4. Financial Health
Financial Snapshot:
| Metric | Value | Source | Assessment |
|---|---|---|---|
| Revenue TTM | $29,867M | TTM through Mar 2026 (Calpine consolidated) | Doubled on Calpine consolidation |
| Revenue Prior Quarter (Q1 2026) | $11,122M | 10-Q filed May 2026 | First full Calpine quarter; doubled YoY |
| Free Cash Flow | ~$1,290M (FY25); $4B+ projected 2026–27 | 10-K FY2025; Q1 2026 8-K May 11, 2026 | Compressed in FY25 on CapEx; rebuilding |
| Cash on Hand | $3,750M | 10-K FY2025 | Adequate; Calpine cash used at close |
| EBITDA | $8,130M TTM | TTM through Mar 2026 | Expanding rapidly post-merger |
| Profit Margin | 12.71% TTM (vs 9.08% FY25) | TTM Mar 2026 | Improving; nuclear mix drives recovery |
| Book Value | $40.21/share (FY25); $11.1B goodwill added Q1 2026 | 10-K FY25; 10-Q Q1 2026 | Diluted by goodwill accretion |
| EPS TTM | $11.51 (diluted) | TTM Mar 2026 | Above pre-Calpine $9.99 baseline |
| Debt/Equity | 1.02x (FY25 pre-Calpine); LTD now $16,994M | 10-Q Q1 2026 | Elevated; Calpine debt absorbed |
| P/E TTM | 24.9x ($286.31 / $11.51) | Computed | Moderate for nuclear-premium franchise |
| Forward P/E | 24.4x ($11.50 midpoint FY26 guidance) | Guidance affirmed May 11, 2026 | Reasonable given 20%+ EPS growth target |
FY25 income context (pre-Calpine): Revenue $25.5B (+8.3% YoY), Net Income $2.3B (-38.1% YoY), Operating Margin 12.1% (vs 18.5% FY24). FY25 reflected the roll-off of normalized power-price tailwinds + Calpine deal costs. Q1 2026 reset the run-rate: EPS $2.74 vs $2.56 est (+7.0% beat) on $11.1B revenue.
Valuation vs Peers:
| Metric | CEG | VST | NEE | Sector Avg |
|---|---|---|---|---|
| P/E TTM | 24.9x | 25.7x | 24.4x | ~20–22x |
| Forward P/E | 24.4x | 16.1x | 23.9x | ~18x |
| P/B | 7.1x | ~8.5x | ~2.9x | ~2.0–2.5x |
| EV/EBITDA | ~14x TTM | 10.4x | 17.3x | ~10–12x |
| Revenue Growth TTM | +23.4% | +43% | ~8% | ~3–5% |
| Profit Margin | 12.71% | 11.5% | ~18% (regulated) | ~10–12% |
Sources: stockanalysis.com (CEG, VST TTM May 2026); gurufocus.com / public.com (NEE, May 26, 2026); industry medians per gurufocus.com regulated utility composite.
5. Ownership & Capital Structure
Active / hedge-fund holders (excluding index arms):
| Holder | Shares | Value | Change | Notes |
|---|---|---|---|---|
| ECP ControlCo, LLC | 22.04M | $6.36B | NEW (Jan 2026) | Energy Capital Partners; received CEG shares as Calpine consideration (13G filed Jan 14, 2026) |
| Vanguard Capital Mgmt (active) | 20.14M | $5.81B | NEW | Active/Wellington-managed sub-advisor arm |
| Vanguard Portfolio Mgmt (active) | 15.01M | $4.33B | NEW | Active sub-advisor arm |
| Capital International Investors | 11.61M | $3.35B | -31.0% | Active fundamental; significant trim since peak |
ECP ControlCo LLC is the managing-member entity of Energy Capital Partners, Calpine's pre-merger PE owner. ECP received ~50M CEG shares (13.8% of post-close share count) at deal close; the 22M figure reflects retained position post partial LP distribution.
Recent Funding / Capital Actions:
- Calpine close (Jan 7, 2026): $21.84B total consideration — 50M new CEG shares + $4.34B cash; 13.8% dilution. $11.1B of goodwill on balance sheet.
- Debt exchange (Jan 15, 2026): ~$2.29B Calpine legacy notes exchanged to Constellation-branded paper; new proceeds + cash repaid $2.5B term loans and $1.25B Calpine first-lien notes. Long-term debt March 31, 2026: $16.99B (vs $14.79B FY25 close). Q1 2026 interest expense $253M (+73% YoY).
- Dividend raised 10% Feb 2026: quarterly $0.3878 → $0.4265; annualized $1.706 (0.59% yield). Next payment June 5, 2026.
- $5.0B buyback authorization announced at post-Calpine investor day; replaces completed $2.36B 2023 program. Funded by projected $4B+ FCF in 2026–27.
- Insider activity (12M): 11 buys / 10 sells, net -72,191 shares. April 28, 2026: four directors each received 556 deferred stock units at $305.71 (Code A board grants, not open-market). No credible open-market (Code P) insider purchases identified in 2025–2026 SEC filings — the absence is notable at the current 29% drawdown.
6. Competition & Sector
| Company | Ticker | Mkt Cap (May 2026) | Generation Mix |
|---|---|---|---|
| Vistra Corp | VST | ~$35B | ~67% nat gas, ~15% nuclear, ~18% other |
| NextEra Energy | NEE | ~$155B | ~55% wind/solar, ~15% gas, ~8% nuclear (regulated) |
| Talen Energy | TLN | ~$5B | ~60% nuclear (Susquehanna), ~35% gas; Amazon 960 MW PPA |
| Public Service Enterprise | PEG | ~$44B | ~60% nuclear (Salem, Hope Creek), regulated NJ |
| Duke Energy | DUK | ~$90B | ~40% gas, ~35% coal/other, ~15% nuclear (regulated) |
Tailwinds:
- AI/data-center power demand. 13 announced nuclear-for-data-center projects (>9.8 GW) globally as of May 2026; CEG is the dominant US counterparty.
- PJM capacity market price surge. 2027/28 BRA cleared at the $333.44/MW-day cap; CEG cleared ~17.95 GW = ~$2.2B capacity revenue. 2028/29 auction in June 2026 faces structural supply shortfall.
- Federal / regulatory support. $1B DOE loan to Crane restart; NRC license renewals through 2047–2051; bipartisan political tailwind for nuclear as AI-era baseload.
Headwinds:
- Calpine integration / leverage. $11.1B goodwill exposed to impairment if synergies miss or gas spreads compress; net debt nearly doubled; interest expense +73% YoY in Q1 2026.
- Hyperscaler capex moderation. The -29% drawdown reflects fears that hyperscaler AI infra spending decelerates. Short interest 10.5M shares concentrated on this thesis.
- Crane (TMI Unit 1) interconnection risk. PJM studies suggest grid connection could slip into the 2030s without FERC approval of the Eddystone injection rights transfer (CEG filed April 2026). Adverse ruling pushes $300–400M/yr Microsoft PPA revenue out and strands $1.6B in-progress capex.
7. 12-Month Catalyst Timeline
| Date/Quarter | Catalyst | Type | Impact |
|---|---|---|---|
| Jun 5, 2026 | Q2 2026 dividend payment ($0.4265/sh; ex May 15) | Income | Neutral; confirms capital return |
| Jun 30, 2026 | PJM 2028/2029 Base Residual Auction | Earnings inflection | High: clear at/near cap with ~18–20 GW adds ~$2.2B+ FY28 capacity revenue; Street re-rates forward earnings |
| Q2 2026 (~Aug) | Q2 2026 earnings — first full two-Q Calpine consolidation | Earnings | Medium: confirmation of synergy trajectory |
| Q3 2026 | FERC Eddystone transfer ruling; NRC RAI response on Crane | Regulatory | High: favorable FERC ruling unblocks 2027 interconnection; adverse ruling delays Crane to 2029+ |
| Q4 2026 | NRC final safety evaluation report on Crane restart license amendment | Regulatory / operational | High: NRC approval clears last federal hurdle for 2027 restart |
| Q4 2026 (2H) | LS Power $5B PJM gas divestiture close (pending DOJ/FERC) | Regulatory | Medium: clears Calpine overhang but reduces pro-forma EBITDA |
| Dec 2026 | PJM 2027/2028 capacity delivery year begins June 1, 2027 | Revenue recognition | Medium: ~$2.2B capacity revenue stream begins flowing |
| Jan 2027 | Meta Clinton PPA ramp prep (1.1 GW, contract starts June 2027) | PPA execution | Medium: ~$200–250M/yr incremental revenue |
| Q1 2027 (~Mar) | Crane (TMI Unit 1) fuel-load target (if FERC/NRC milestones hit) | Operational | Very High: 835 MW restart powers Microsoft AI; ~$300–400M/yr PPA revenue begins |
8. Recent News
| Date | Outlet | Headline | Material? |
|---|---|---|---|
| May 13, 2026 | Motley Fool / Yahoo Finance | Argus cuts PT from $425 to $350 on utility-sector multiple compression; stock slumps 6%+ | Yes — crystallizes the "leveraged utility" re-rate |
| May 9, 2026 | Business Wire / Investing.com | Q1 2026 results: Adj EPS $2.74 vs $2.56 est; rev $11.1B vs $9.0B est; FY26 guide $11–$12 reaffirmed | Yes — anchors the bull case |
| May 7, 2026 | Bloomberg | TMI (Crane Clean Energy Center) restart ~80% staffed; DOE $1B loan guarantee Nov 2025; first power 2027–28 | Yes — timeline slippage adds uncertainty |
| Apr 21, 2026 | Barron's / Insider Monkey | Evercore ISI resumes Outperform / $380; Morgan Stanley cuts PT $385→$360 (maintains OW) | Yes — divergent PT moves; analyst repricing of risk premium |
| Mar 18, 2026 | Business Wire / Power Engineering | Constellation agrees to sell 4.4 GW PJM gas assets to LS Power for $5B as DOJ/FERC Calpine divestiture | Yes — clears regulatory overhang; raises execution risk |
| Jan 7, 2026 | Yahoo Finance / TipRanks | Calpine acquisition closes; 50M new CEG shares + $4.5B cash; combined fleet 55 GW | Yes — transformational close; near-term dilution |
| Jun 3, 2025 | Power Engineering / Data Center Dynamics | Meta 20-year PPA for full output of Clinton (1.1 GW) starting June 2027 | Yes — validates hyperscaler nuclear template beyond MSFT |
| Sep 2024 | Reuters / World Nuclear News | Microsoft-Constellation TMI PPA: 835 MW, 20-year dedicated AI data center load | Yes — foundational trade that triggered Oct 2025 ATH |
9. M&A & Rumor Watch
Calpine — closed, divestitures in flight.
- Closed January 7, 2026. Consideration: 50M newly issued CEG shares + $4.5B cash; total EV ~$16.4B. Combined fleet ~55 GW (~60 GW pre-divestiture).
- FERC approved July 2025; DOJ resolution Dec 2025 (mandated PJM gas divestitures).
- March 18, 2026: Constellation announced sale of
4.4 GW PJM gas (Bethlehem, York 1 & 2, Hay Road, Edge Moor) to LS Power for $5B ($1,142/kW). Close expected 2H 2026, pending DOJ/FERC sign-off.
Other M&A: No credible activity on additional acquisitions. Reporting focuses on integration and divestiture execution.
Insider Form 4 review:
- Apr 28, 2026: four directors each received 556 deferred stock units at $305.71 — Code A board grants, not Code P open-market.
- Jan 9, 2026: Daniel L. Eggers (SEVP Finance) received 5,840 RSUs — comp grant.
- Feb 11, 2026: Eggers exercised vested awards, disposed at $272.15 — routine tax withholding.
- Jan 7, 2026: Andrew R. Novotny received 298,853 shares connected to Calpine close.
- No credible open-market (Code P) insider purchases in 2025–2026. The absence at -29% from ATH is a quiet but telling non-signal.
Activist / 13D-G: No credible activist filings for CEG in the past 12 months. ECP ControlCo 13G (Jan 14, 2026) is a passive ownership disclosure from the Calpine deal consideration.
Rumors: No credible M&A rumors with specific outlet attribution.
10. Social Sentiment
- Overall mood: Mixed-to-Bearish short-term, with a bullish structural undercurrent among long-duration holders. Sentiment score: 2.8 / 5
- Retail vs Institutional: Retail (Reddit / fintwit) remains constructively positioned on the nuclear-AI thesis — AltIndex tracks ~80/100 bullish Reddit score, but mention volume is low (~10th percentile; not a meme candidate). Institutional sentiment is more divided: sell-side consensus 79–86% Buy with avg PT ~$375 (implying ~31% upside), but Q1 saw trimming and at least six analysts cut forward EPS estimates post-Calpine.
- Trending narratives:
- Calpine dilution overhang — 50M new shares + ~$17B pro-forma debt shifted the story from pure-play nuclear premium to "leveraged utility." Argus's May 13 downgrade crystallized this re-rate.
- Nuclear-AI scarcity premium vs hyperscaler capex slowdown — Q1 narrative was capex-moderation fear; Q1 beat + reaffirmed guide partially defused.
- Crane (TMI) timeline slippage — 80% staffed, first power 2027–28 vs. original 2026 messaging. NRC final sign-off is the swing variable.
- Notable voices:
- Morgan Stanley (utility/power team) — Overweight; PT $360 (cut from $385 in April 2026). Bullish long-term contracted revenue, flagging near-term leverage.
- Evercore ISI — Resumed Outperform at $380 on April 21, 2026; argued Calpine adds diversified dispatch flexibility offsetting nuclear-only concentration.
- Argus (John Eade) — May 2026 downgrade to $350; key bear voice pushing utility-comps valuation discipline.
- Sentiment shift (past 30 days): Mildly positive. May 9 Q1 beat drove 4%+ pre-market pop and arrested the May selloff. May 13 Argus downgrade re-introduced a -6% leg. Net: moved from "actively deteriorating" to "tentatively stabilizing." Reaffirmed FY26 $11–$12 EPS guide at ~26x midpoint is the anchor keeping institutional buyers engaged.
11. Bull vs Bear Case
| Bull Case ($380+) | Bear Case ($240–250) |
|---|---|
| Nuclear scarcity premium re-asserts as Crane restart NRC-approved Q4 2026 | FERC denies Eddystone transfer; Crane slips to 2029+; $1.6B capex stranded |
| PJM 2028/29 BRA clears near cap → adds $2.2B+ FY28 capacity revenue | Hyperscaler AI capex moderates; new PPA pricing rolls over; PPA growth thesis stalls |
| $5B buyback at depressed prices is EPS-accretive; 20%+ guided EPS CAGR validates 30x fwd P/E | Calpine integration falters; $11.1B goodwill faces impairment; gas margin compression |
| 20-year MSFT + Meta PPAs lock in multi-decade contracted revenue from IG counterparties | Interest expense already +73% YoY; rate compression slows OCF recovery |
| ECP overhang already in market via 13G; short interest is digesting, not threatening | Doubled short interest + death-cross signal further institutional unloading ahead |
| Sell-side avg PT ~$375 reflects underlying analyst conviction | No open-market insider buying at -29% drawdown is a tacit "not cheap enough yet" |
12. The Verdict
| Field | Value |
|---|---|
| Rating | BUY (stage-in) |
| Fair Value | $345 (+20% from $286.31) |
| 12-Month Price Target | $335 (+17%) |
| Bull Case | $380+ |
| Bear Case | $240–250 |
| Entry Zone | $273–$283 (50MA support / S1 cluster reclaim) |
| Stop Loss | $242 (below S1 $247.06) |
| Conviction | Medium |
| Time Horizon | 12–18 months |
| Position Sizing | Stage in: 1/3 at $283, 1/3 at $260, 1/3 on confirmed 50MA reclaim above $293 |
| Key Catalyst | PJM 2028/29 BRA (Jun 2026) → FERC Eddystone ruling (Q3 2026) → NRC Crane final approval (Q4 2026) |
| Key Risk | FERC denial of Eddystone capacity injection transfer pushing Crane (TMI Unit 1) restart to 2029+, stranding $1.6B capex and eliminating $300–400M/yr Microsoft PPA from near-term estimates while doubled short base exploits the miss |
Synthesis: The structural bull case (60 GW fleet, 20-year hyperscaler PPAs, $5B buyback, reaffirmed $11–$12 FY26 EPS guide) is intact and concrete. The price decline from $403.95 → $286.31 has correctly de-rated the stock from a semiconductor-adjacent multiple to a leveraged-utility multiple, and the doubled short interest reads as smart-money pressing the leverage trade — not squeeze fuel. The catalyst path from June 2026 (PJM auction) through Q1 2027 (Crane fuel load) is concrete and calendared; absent execution stumbles, the FY26 $11–$12 EPS guide at 28–30x forward P/E gets to $322–$360, validating our $335 target. We recommend staging in over the $260–$290 corridor rather than chasing — Ant's 50MA-reclaim trigger is the tactical confirmation, and the absence of open-market insider buying argues this is not yet "obvious bottom" pricing.
Disclaimer: For informational purposes only. Not investment advice. Past performance is not indicative of future results. Do your own research before making investment decisions.